Tender detail
Conclusion of a discount agreement for Perampanel
Summary
The tender concerns the conclusion of non-exclusive discount agreements for medicines containing the active substance Perampanel for the period from 1 September 2026 to 31 August 2028, with an option to extend the contract once for 12 months. The bidder should note that DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible, and that the medicines to be specified in Annex 2 to the contract must be named in the bid.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.